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Abstract: Several imaging modalities exist for the detection of parathyroid
adenomas in patients with primary hyperparathyroidism. Unlike solitary
parathyroid adenoma, parathyroid hyperplasia in patients with secondary
hyperparathyroidism hitherto is difficult to assess with any imaging mo-
dality. Our case of a young patient with chronic kidney failure illustrates
that 18F-fluorocholine PET/MR might be an imaging tool suitable for the
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FIGURE 1. Conventional dual-isotope scintigraphy of the neck in a 35-year-old man with chronic kidney failure and
clinical suspicion of autonomous parathyroid hormone (PTH) secretion. During the last 7 months, the patient’s serum PTH
concentration was increasing from 830 to 1130 ng/L (reference range, 15–65 ng/L), whereas the serum calcium concentration
was normal. Coronal 99mTc-tetrofosmin image (A), 123I image (B), and subtraction image (C) reveal no suspicious lesion in the
neck or upper mediastinum. Ultrasonography (not shown) was negative as well.
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FIGURE2. 18F-fluorocholine PET/MR imagingof the neck acquired3weeks later. Coronal 18F-fluorocholine PET image (A) shows
4 small active lesions (arrows), situated bilaterally at the upper and lower end of the thyroid gland. Inferior lesions are most
prominent. Axial T2-weighted fat-suppressedMR image (B) and 18F-fluorocholine PET/MR image (C) at the level of the left-sided
inferior lesion reveal a small hyperintense nodule (arrow) between thyroid gland and longus colli muscle (asterisk). Along with
the patient’s clinical history, these imaging findings are consistent with parathyroid hyperplasia. Secondary hyperparathyroidism
occurs in patients with chronic kidney failure or other causes of vitamin D deficiency such as malabsorption. The lack of
bioactive calcitriol (1,25-dihydroxyvitamin D3) causes hypocalcemia, which is corrected by an appropriate increase in PTH
synthesis. Tertiary hyperparathyroidism develops if this endocrine relationship is uncoupled and PTH secretions increase
despite normal or even elevated serum calcium. In both conditions, parathyroid hyperplasia represents the typical
histopathologic correlate. Surgical therapy can be curative, and usually all parathyroid glands but the smallest one are
resected. The current imaging standard in patients with hyperparathyroidism is dual-tracer subtraction scintigraphy using
99mTc-tetrofosmin and 123I, together with ultrasonography.1,2 The sensitivity and specificity of these methods are high
(approximately 90%) in patients with single parathyroid adenomas, but lower (30%–80%) if multiple gland pathology
is present.3–6 Negative imaging findings in patients with hyperparathyroidism are a problem.7 Recently, dynamic
contrast-enhanced CT imaging and choline PET/CT imaging have been advocated to identify parathyroid adenomas if
conventional imaging was negative.8–13 Normally functioning parathyroid glands are not seen on choline PET images, but
occasionally incidental parathyroid adenomas are found in patients undergoing prostate cancer staging with choline PET,
and hitherto unnoticed primary hyperparathyroidism is revealed.11,14,15 Secondary hyperparathyroidism and tertiary
hyperparathyroidism most often result in asymmetrical parathyroid gland hyperplasia and only subtle glandular enlargement,
as seen in our case.1,16,17 The inferior parathyroid glands usually are more hyperplastic than the superior parathyroid glands.
18F-fluorocholine PET/CT has been suggested as first-line imaging modality for the detection of hyperfunctioning parathyroid
glands in patients with secondary hyperparathyroidism.11,18 We believe that 18F-fluorocholine PET/MR might be even more
suitable, owing to less radiation exposure and higher soft-tissue contrast of MR, allowing for a morphological correlation
of PET findings. 18F-fluorocholine PET/MR might also aid surgical planning, confirming not only the presence of parathyroid
hyperplasia, but also mapping the location and size of hyperplastic parathyroid glands.
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